BSAC Infection Learning Hub
Open access global learning
All courses accredited

SPONSORED WEBINAR

Webinar: Is it possible to have a one-stop antibiotic for surgical site infections?

Thursday 3rd September 2020 1700-1830

This webinar will consist of the following presentations:

‘The continuing challenges of treating surgical site infections – a surgeon’s perspective’ 

Shervanthi Homer-Vanniasinkam

 Treatment options and pathways. Where does a new fluoroquinolone sit? 

Mark Wilcox

Panel discussion 

Q& A 

Click here to view QUOFENIX ▼ (delafloxacin) Prescribing Information.
This course is intended for healthcare professionals.
Supported and funded by A. Menarini Farmaceutica Internazionale S.r.l. including honoraria in accordance with the ABPI Code of Practice.
PP-QUO-UK-0030 | August 2020


Speakers/Presenters
  • Professor Shervanthi Homer-Vanniasinkam, BSc, MBBS, MD, FRCSEd, FRCS

    Professor Shervanthi Homer-Vanniasinkam is a Consultant Vascular Surgeon at Leeds Teaching Hospitals NHS Trust. She is also the Founding Director of EXSEL (a novel medical student scholarship scheme), at the University of Leeds Medical School, the Founding Professor of Surgery at the University of Warwick Medical School & University Hospitals Coventry and Warwickshire, and Professor of Engineering & Surgery at University College London.
    She has published 150 papers and book chapters (H index 40), delivered over 300 presentations, and has a significant research grant portfolio. She has an outstanding track record of national (Universities of Leeds, London, Warwick) and international (Harvard, Yale, Singapore, India, Sri Lanka) collaborative research. She is a Visiting Scholar at Harvard University, the Yeoh Ghim Seng Visiting Professor of Surgery at the National University of Singapore and the Brahm Prakash Visiting Professor at the Indian Institute of Science.

  • Professor Mark Wilcox, Professor of Medical Microbiology

    Prof. Mark Wilcox is a consultant microbiologist and the Head of Research and Development in Microbiology at the Leeds Teaching Hospitals (LTHT), where he is also the Infection Lead of Leeds NIHR Diagnostic Technologies Medical Technology and In Vitro Diagnostic Co-operative; Professor of Medical Microbiology at the University of Leeds; and Lead on Clostridium difficile for Public Health England (PHE). He serves in multiple advisory roles including to UK SAGE (COVID-19), as a medical advisor to the National Infection Prevention & Control Lead (NHSImprovement/England, the Medical Research Council’s Infection and Immunity Panel, as Chair of PHE’s Rapid Review Panel (reviews the utility of infection prevention & control products for the NHS) and member of the UK NHS Antimicrobial Resistance Programme Board.

    He was formerly the Director of Infection Prevention (4 years), Infection Control Doctor (8 years), and Clinical Director of Pathology (6 years) at LTHT and Head of Microbiology (15 years).

    Prof Wilcox leads a Healthcare Associated Infection Research Group at the University of Leeds (http://medhealth.leeds.ac.uk/hcai), comprising ~30 doctors, scientists and nurses. Projects include multiple aspects of Clostridium difficile infection, diagnostics, antibiotic resistance and the gut microbiome, infection prevention and control interventions, and the clinical development of new antimicrobial agents.

Support For Delegates

For any Delegates joining our webinars, the following browsers are supported:

Desktop
Please use Chrome, Firefox, Safari and Edge.
Here are the minimum version requirements for each browser:
Chrome 55+
Firefox 53+
Safari 12.1+
Edge 42

Mobile
Delegates joining a webinar via their mobile will be able to join directly through their Unique Join Link issued at registration.

Top